Zobrazeno 1 - 10 of 4 731 pro vyhledávání: '"Erdmann, S"'
1
Akademický článek
Genome-wide CRISPR-Cas 9 screens identify BCL family members as modulators of response to regorafenib in experimental glioma.
Autor: Haeusser LA; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; German Cancer Consortium (DKTK), partner site Tübingen, a partnership between DKFZ and University Hospital Tübingen; Tübingen and Heidelberg, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany., Becker H; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany.; Department of Neurosurgery, University Hospital Tübingen, Eberhard Karls University Tübingen; Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, Eberhard Karls University Tübingen; Tübingen, Germany., Kuhlburger L; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany.; Quantitative Biology Center, Eberhard Karls University Tübingen; Tübingen, Germany.; Biomedical Data Science, Department of Computer Science, Eberhard Karls University Tübingen; Tübingen, Germany., Zago M; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; Department of Internal Medicine I, University Hospital Tübingen; Tübingen, Germany.; M3 Research Center for Malignome, Metabolome and Microbiome, Faculty of Medicine, Eberhard Karls University Tübingen; Tübingen, Germany.; Department of Computer Science, Eberhard Karls University Tübingen; Tübingen, Germany.; Institute of Biomedical Informatics, University Hospital Tübingen, Eberhard Karls University Tübingen; Tübingen, Germany., Walter B; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany., Tsiami F; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany., Erdmann S; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; German Cancer Consortium (DKTK), partner site Tübingen, a partnership between DKFZ and University Hospital Tübingen; Tübingen and Heidelberg, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany., Trampert J; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany., Surender S; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany., Stahl A; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany., Templin M; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany., Wegner E; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany., Schmidt T; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany., Schmees C; NMI Natural and Medical Sciences Institute, University of Tübingen, Reutlingen, Germany., Casadei N; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany., Sevenich L; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; German Cancer Consortium (DKTK), partner site Tübingen, a partnership between DKFZ and University Hospital Tübingen; Tübingen and Heidelberg, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany.; M3 Research Center for Malignome, Metabolome and Microbiome, Faculty of Medicine, Eberhard Karls University Tübingen; Tübingen, Germany., Claassen M; Department of Internal Medicine I, University Hospital Tübingen; Tübingen, Germany.; M3 Research Center for Malignome, Metabolome and Microbiome, Faculty of Medicine, Eberhard Karls University Tübingen; Tübingen, Germany.; Department of Computer Science, Eberhard Karls University Tübingen; Tübingen, Germany.; Institute of Biomedical Informatics, University Hospital Tübingen, Eberhard Karls University Tübingen; Tübingen, Germany., Nahnsen S; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany.; Quantitative Biology Center, Eberhard Karls University Tübingen; Tübingen, Germany.; Biomedical Data Science, Department of Computer Science, Eberhard Karls University Tübingen; Tübingen, Germany.; M3 Research Center for Malignome, Metabolome and Microbiome, Faculty of Medicine, Eberhard Karls University Tübingen; Tübingen, Germany., Beck S; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany., Merk DJ; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany., Tabatabai G; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen; Tübingen, Germany.; German Cancer Consortium (DKTK), partner site Tübingen, a partnership between DKFZ and University Hospital Tübingen; Tübingen and Heidelberg, Germany.; Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen; Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, Eberhard Karls University Tübingen; Tübingen, Germany.
Publikováno v: Neuro-oncology [Neuro Oncol] 2025 Jan 04. Date of Electronic Publication: 2025 Jan 04.
Zobrazit plný text záznamu
2
Akademický článek
A multivariable disease-specific model enhances prognostication beyond current Merkel cell carcinoma staging: An international cohort study of 10,958 patients.
Autor: Andrew TW; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; Department of Plastic and Reconstructive Surgery, Royal Victoria Infirmary, Newcastle Upon Tyne Hospital NHS Foundation Trust (NuTH), Newcastle upon Tyne, UK. Electronic address: tom.andrew@nhs.net., Erdmann S; Department of Plastic and Reconstructive Surgery, Royal Victoria Infirmary, Newcastle Upon Tyne Hospital NHS Foundation Trust (NuTH), Newcastle upon Tyne, UK., Alrawi M; Department of Plastic and Reconstructive Surgery, Royal Victoria Infirmary, Newcastle Upon Tyne Hospital NHS Foundation Trust (NuTH), Newcastle upon Tyne, UK., Plummer R; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; Department of Oncology, Newcastle University and Northern Centre for Cancer Care, Newcastle upon Tyne, UK., Shalhout SZ; Division of Surgical Oncology, Department of Otolaryngology-Head and Neck Surgery, Mike Toth Head and Neck Cancer Research Center, Mass Eye and Ear, Boston, Massachusetts; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts., Sondak V; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida., Brownell I; Dermatology Branch, National Institute of Arthritis Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, Maryland., Lovat PE; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Rose A; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; Department of Plastic and Reconstructive Surgery, Royal Victoria Infirmary, Newcastle Upon Tyne Hospital NHS Foundation Trust (NuTH), Newcastle upon Tyne, UK.
Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Nov 20. Date of Electronic Publication: 2024 Nov 20.
Zobrazit plný text záznamu
5
Akademický článek
Implementation of integrated care for type 2 diabetes Mellitus and Periodontitis in Germany: study protocol for a practice-based and cluster-randomized trial.
Autor: Hennrich P; Heidelberg Institute of Global Health Section for Oral Health, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. patrick.hennrich@med.uni-heidelberg.de., Queder A; Department for General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany., Altiner A; Department for General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany., Awounvo S; Heidelberg University Hospital Institute of Medical Biometry, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany., Dyczmons J; Düsseldorf University Hospital Institute for Health Services Research and Health Economics, Moorenstr. 5, 40225, Düsseldorf, Germany., Eigendorf J; aQua-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany., Erdmann S; Heidelberg University Hospital Institute of Medical Biometry, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany., Grobe T; aQua-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany., Gutscher A; aQua-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany., Herzig N; Techniker Krankenkasse, Bramfelder Str. 140, 22305, Hamburg, Germany., Jepsen S; Department of Periodontology, Operative and Preventive Dentistry, Bonn University Hospital, Welschnonnenstr. 17, 53111, Bonn, Germany., Kairies-Schwarz N; Düsseldorf University Hospital Institute for Health Services Research and Health Economics, Moorenstr. 5, 40225, Düsseldorf, Germany., Kalmus O; Heidelberg Institute of Global Health Section for Oral Health, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany., Kliemannel F; aQua-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany., Santos S; Düsseldorf University Hospital Institute of General Practice, Moorenstr. 5, 40225, Düsseldorf, Germany., Vanella P; aQua-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, Maschmühlenweg 8-10, 37073, Göttingen, Germany., Wensing M; Department for General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany., Wilm S; Düsseldorf University Hospital Institute of General Practice, Moorenstr. 5, 40225, Düsseldorf, Germany., Listl S; Heidelberg Institute of Global Health Section for Oral Health, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
Publikováno v: BMC oral health [BMC Oral Health] 2024 Aug 02; Vol. 24 (1), pp. 879. Date of Electronic Publication: 2024 Aug 02.
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje